BusinessMedical Marijuana, Inc. Portfolio Investment Company, Kannalife Sciences, Inc.’s New Cannabis-Derived Compound KLS-13019 Covered by Reuters, Kannalife Explores IPO This YearBy Nasdaq OMXFeb 26, 2016, 2:00 PM UTC